Zobrazeno 1 - 10 of 17 pro vyhledávání: '"Miguel Tregnaghi"'
1
Akademický článek
Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers
Autor: Miguel Tregnaghi, Pio Lopez, Daniel Stamboulian, Gabriela Graña, Tatjana Odrljin, Lisa Bedell, Peter M. Dull
Publikováno v: International Journal of Infectious Diseases, Vol 26, Iss C, Pp 22-30 (2014)
Objectives: This phase III study assessed the safety and immunogenicity of MenACWY-CRM, a quadrivalent meningococcal conjugate vaccine, administered with routine vaccines starting at 2 months of age. Methods: Healthy infants received MenACWY-CRM in a
Externí odkaz: https://doaj.org/article/84d8456e81054a57b16817da14255e1c
Zobrazit plný text záznamu
2
Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers
Autor: Gabriela Graña, Tatjana Odrljin, Pio Lopez, Miguel Tregnaghi, Daniel Stamboulian, Lisa Bedell, Peter M. Dull
Publikováno v: International Journal of Infectious Diseases, Vol 26, Iss C, Pp 22-30 (2014)
Summary Objectives This phase III study assessed the safety and immunogenicity of MenACWY-CRM, a quadrivalent meningococcal conjugate vaccine, administered with routine vaccines starting at 2 months of age. Methods Healthy infants received MenACWY-CR
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::539593d652b670eed0d19f48e52476d3
https://doi.org/10.1016/j.ijid.2014.03.1390
Zobrazit plný text záznamu
3
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine and Commonly Administered Vaccines After Coadministration
Autor: Roberto Gasparini, Linda Han, Miguel Tregnaghi, Igor Smolenov, Pavitra Keshavan, Ellen Ypma
Publikováno v: The Pediatric infectious disease journal. 35(1)
Background Given the broad age range across which the quadrivalent meningococcal conjugate vaccine MenACWY-CRM is used, coadministration with routine vaccines should be evaluated across age groups for possible immunologic interference and impact on v
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8981632e6f7ac2e36d40374acc628819
https://pubmed.ncbi.nlm.nih.gov/26398743
Zobrazit plný text záznamu
4
A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America Nueva vacuna combinada DTPw-HB/Hib para la vacunación primaria y de refuerzo de menores de un año en América Latina
Autor: Miguel Tregnaghi, Pio López, Crisanta Rocha, Luis Rivera, Marie-Pierre David, Ricardo Rüttimann, Lode Schuerman
Publikováno v: Revista Panamericana de Salud Pública, Vol 19, Iss 3, Pp 179-188 (2006)
OBJECTIVES: In 1998 the World Health Organization (WHO) recommended the inclusion of Haemophilus influenza type B (Hib) conjugate vaccines in infant immunization programs, whenever in accordance with national priorities. GlaxoSmithKline Biologicals h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::3e98afaa93e5601b24f26940fe3f370d
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000300006
Zobrazit plný text záznamu
5
Comparison of two recombinant hepatitis B vaccines and their interchangeability in Argentine infants Comparación de dos vacunas recombinantes contra la hepatitis B y su intercambiabilidad en lactantes argentinos
Autor: Miguel Tregnaghi, José Ussher, Ana María Baudagna, Miriam Calvari, Gabriela Graña
Publikováno v: Revista Panamericana de Salud Pública, Vol 15, Iss 1, Pp 35-40 (2004)
OBJECTIVE: To compare two pediatric recombinant hepatitis B vaccines-the Engerix-B reference vaccine and the Euvax-B vaccine-in terms of immunogenicity and reactogenicity, and also to investigate their interchangeability, that is, whether a three-dos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::97dfd0c8f571aa0115f1bcc9246b133c
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100006
Zobrazit plný text záznamu
6
Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2-, 4-, and 6-month-old Argentinean infants
Autor: Eduardo Santos-Lima, Betzana Zambrano, Miguel Tregnaghi
Publikováno v: The Pediatric infectious disease journal. 30(6)
Background and aims Assessment of a new, fully liquid, investigational hexavalent DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim, Sanofi Pasteur), containing the same active ingredients as Pentaxim (DTaP-IPV//PRT-T) and 10 μg Hansenula polymorpha-derived rec
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3f1246969cf6c81998e59a467623ba1
https://pubmed.ncbi.nlm.nih.gov/21372751
Zobrazit plný text záznamu
7
Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial
Autor: Katia Abarca, Jeanne-Marie Jacquet, Javier Casellas, Alix Collard, Miguel Tregnaghi, Inge Lefevre, Angela Gentile, Felix Espinoza
Publikováno v: BMC Infectious Diseases, Vol 10, Iss 1, p 297 (2010)
BMC Infectious Diseases
Background Diphtheria-tetanus-whole-cell pertussis (DTPw)-based combination vaccines are an attractive option to rapidly achieve high coverage and protection against other important pathogens, such as hepatitis B virus (HBV) and Haemophilus influenza
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ca25bb0cec7ae2576a4d2e6f5d1be08
http://www.biomedcentral.com/1471-2334/10/297
Zobrazit plný text záznamu
8
Active epidemiologic surveillance of pneumonia and invasive pneumococcal disease in ambulatory and hospitalized infants in Cordoba, Argentina
Autor: José Ussher, Pablo Tregnaghi, William P. Hausdorff, Miguel Tregnaghi, Ana Ceballos, Pascal Peeters, Ricardo Rüttimann
Publikováno v: The Pediatric infectious disease journal. 25(4)
Active surveillance of ambulatory and hospitalized children 2-23 months old in Cordoba, Argentina for invasive pneumococcal disease and radiographically confirmed "obvious" pneumonia revealed annual incidences of 206.8 and 2422 cases, respectively, p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53970342e3ca5596033c6a5a7f211463
https://pubmed.ncbi.nlm.nih.gov/16567994
Zobrazit plný text záznamu
9
Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age
Autor: Marcela Potin, Sofía Navarro, Ricardo Rüttimann, José Ussher, Joanne Wolter, Lode Schuerman, Rodrigo Vergara, Miguel Tregnaghi
Publikováno v: European journal of pediatrics. 164(6)
High rates of pertussis disease in adolescents suggest that additional boosting against pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine (dTpa-IPV; Boostrixtrade mark Polio, n =440) was compared to separately a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f34bc365c82ccb3e1eabd4fcae74ce79
https://pubmed.ncbi.nlm.nih.gov/15782295
Zobrazit plný text záznamu
10
Invasive infections caused by Strep. pneumoniae: an epidemiological study and the importance of developing a monitoring system
Autor: Raúl Ruvinsky, Ángela Gentile, Mabel Regueira, Alejandra Corso, Angela Gentile, Julio Pace, Julia Bakir, José Luis Di Fabio, Alicia Rossi, Marta Altschuler, Silvia González Ayala, Claudia Hernández, Etelvina Rubeglio, Rosa Bologna, Sara Grenón, Marta Von Specht, Claudia Mayoral, Juan Carlos Beltramino, Laura Carabajal, Raquel Silverberg, María José Rial, Nora Alarcón, Fernando Ferrero, Susana Yudowski, Miguel Tregnaghi, Laura Balbi de Aguirre, Ernestina Q. Aprá, Mabel Vázquez, Laura Galanternic, Adriana Procopio, Daniel Logarzo, Aída L Meccia, Clara Kremer, Carlota Pérez, Nélida Cuza, Ana Villagra de Trejo, María Cristina Lura de Calafell, Judith Pierini de Gaite, Rosa Fabre, Ricardo Dalamón, Miriam Bruno, Nora Díaz, Marta Noriega, Diana Gómez
Publikováno v: Revista chilena de pediatría, Volume: 75, Issue: 1, Pages: 77-79, Published: JAN 2004
Las infecciones invasivas por Streptococcus pneumoniae (Spn) producen mortalidad elevada en países en desarrollo, con tasas entre 4 y 100 veces mayores que las de Estados Unidos o Canadá. Es el primer agente causal de neumonía en la infancia y de
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff1f991103ccf5994d073b94e5e609e
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0370-41062004000100013&lng=en&tlng=en
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje